140 related articles for article (PubMed ID: 24800672)
1. Shark protein improves bone mineral density in ovariectomized rats and inhibits osteoclast differentiation.
Uehara K; Takahashi A; Watanabe M; Nomura Y
Nutrition; 2014 Jun; 30(6):719-25. PubMed ID: 24800672
[TBL] [Abstract][Full Text] [Related]
2. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.
Sun D; Krishnan A; Zaman K; Lawrence R; Bhattacharya A; Fernandes G
J Bone Miner Res; 2003 Jul; 18(7):1206-16. PubMed ID: 12854830
[TBL] [Abstract][Full Text] [Related]
3. NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts.
Shimizu H; Nakagami H; Tsukamoto I; Morita S; Kunugiza Y; Tomita T; Yoshikawa H; Kaneda Y; Ogihara T; Morishita R
Gene Ther; 2006 Jun; 13(12):933-41. PubMed ID: 16511526
[TBL] [Abstract][Full Text] [Related]
4. Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats.
Kim J; Kim HK; Kim S; Imm JY; Whang KY
J Med Food; 2015 Dec; 18(12):1349-56. PubMed ID: 26367331
[TBL] [Abstract][Full Text] [Related]
5. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
[TBL] [Abstract][Full Text] [Related]
6. The anti-osteoporotic effect of Yijung-tang in an ovariectomized rat model mediated by inhibition of osteoclast differentiation.
Kim T; Ha H; Shim KS; Cho WK; Ma JY
J Ethnopharmacol; 2013 Mar; 146(1):83-9. PubMed ID: 23219731
[TBL] [Abstract][Full Text] [Related]
7. Low‑molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats.
Jin X; Zhu L; Li X; Jia J; Zhang Y; Sun X; Ma J; Liu Z; Ma X
Mol Med Rep; 2017 Feb; 15(2):890-898. PubMed ID: 28000877
[TBL] [Abstract][Full Text] [Related]
8. Increase in bone mineral density through oral administration of shark gelatin to ovariectomized rats.
Nomura Y; Oohashi K; Watanabe M; Kasugai S
Nutrition; 2005; 21(11-12):1120-6. PubMed ID: 16308135
[TBL] [Abstract][Full Text] [Related]
9. Dietary l-carnitine supplementation improves bone mineral density by suppressing bone turnover in aged ovariectomized rats.
Hooshmand S; Balakrishnan A; Clark RM; Owen KQ; Koo SI; Arjmandi BH
Phytomedicine; 2008 Aug; 15(8):595-601. PubMed ID: 18539446
[TBL] [Abstract][Full Text] [Related]
10. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.
Shu G; Yamamoto K; Nagashima M
Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994
[TBL] [Abstract][Full Text] [Related]
11. The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis.
Lee DG; Park SY; Chung WS; Park JH; Shin HS; Hwang E; Kim IH; Yi TH
Mol Nutr Food Res; 2014 Jun; 58(6):1249-57. PubMed ID: 24604889
[TBL] [Abstract][Full Text] [Related]
12. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).
Duque G; Macoritto M; Dion N; Ste-Marie LG; Kremer R
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E723-30. PubMed ID: 15572658
[TBL] [Abstract][Full Text] [Related]
13. Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss.
Lindberg MK; Svensson J; Venken K; Chavoshi T; Andersson N; Movérare Skrtic S; Isaksson O; Vanderschueren D; Carlsten H; Ohlsson C
Bone; 2006 Jan; 38(1):85-92. PubMed ID: 16257281
[TBL] [Abstract][Full Text] [Related]
14. Growth/differentiation factor-15 inhibits differentiation into osteoclasts--a novel factor involved in control of osteoclast differentiation.
Vanhara P; Lincová E; Kozubík A; Jurdic P; Soucek K; Smarda J
Differentiation; 2009 Nov; 78(4):213-22. PubMed ID: 19695766
[TBL] [Abstract][Full Text] [Related]
15. Additional weight bearing during exercise and estrogen in the rat: the effect on bone mass, turnover, and structure.
Tromp AM; Bravenboer N; Tanck E; Oostlander A; Holzmann PJ; Kostense PJ; Roos JC; Burger EH; Huiskes R; Lips P
Calcif Tissue Int; 2006 Dec; 79(6):404-15. PubMed ID: 17160577
[TBL] [Abstract][Full Text] [Related]
16. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
17. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
18. Disruption of claudin-18 diminishes ovariectomy-induced bone loss in mice.
Kim HY; Alarcon C; Pourteymour S; Wergedal JE; Mohan S
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E531-7. PubMed ID: 23299504
[TBL] [Abstract][Full Text] [Related]
19. Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo.
Hwang YH; Kim KJ; Kim SJ; Mun SK; Hong SG; Son YJ; Yee ST
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562730
[TBL] [Abstract][Full Text] [Related]
20. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
